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ABSTRACT 
 HIV weakens the immune system by infecting and destroying T-cells, leaving the body 
vulnerable to infection and the development of AIDS. Conventional treatments for HIV, such as  
combined anti-rectroviral therapy (cART), fail to prevent the development of HIV-associated 
neurocognitive disorder (HAND). Neurological dysfunction has been directly related to the 
invasion of HIV in the central nervous system (CNS). HIV produces neurotoxic proteins, such as 
the Viral Protein R (Vpr), which contribute to HAND. Astrocytes are the most abundant cells in 
the brain and an important HIV target. We hypothesize that astrocytes expressing Vpr will cause 
neuronal damage in our co-culture system. Primary astrocytes were transfected with Vpr plasmid 
or control (pEGFP or mock) using electroporation. Astrocytes were then co-cultured with 
cortical neurons. At 48 and 72 hours we collected the primary astrocytes to confirm the Vpr 
expression via western blot analysis. We then measured structural damage in the neurons using 
immunofluorescence for cytoskeletal (MAP2, f-actin) and synaptic (synaptophysin) damage. 
Preliminary results showed strong staining of filamentous actin and MAP2 with weak detection 
of synaptophysin. The positive control for neurotoxicity (2.8µM acrylamide) showed substantial 
damage to the cellular structure. Results for Vpr expression are pending. After confirming that 
the immunofluorescence assays are working with our controls, we expect to detect any 
synaptodendritic damage in the neurons caused by Vpr in our upcoming experiments.  
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